Pharmacology

D.J. Mangelsdorf, U. Borgmeyer, R.A. Heyman, et al., "Characterization of three RXR genes that mediate the action of 9-cis retinoic acid," Genes & Development, 6:329-44, 1992. David J. Mangelsdorf (Howard Hughes Medical Institute, University of Texas Southwestern Medical Center, Dallas): "Nuclear hormone receptors are a family of related transcription factors that are activated by binding small hydrophobic hormones like the steroids, thyroxin, vitamin D3, and all-trans retinoic acid. One intri

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

D.J. Mangelsdorf, U. Borgmeyer, R.A. Heyman, et al., "Characterization of three RXR genes that mediate the action of 9-cis retinoic acid," Genes & Development, 6:329-44, 1992.

David J. Mangelsdorf (Howard Hughes Medical Institute, University of Texas Southwestern Medical Center, Dallas): "Nuclear hormone receptors are a family of related transcription factors that are activated by binding small hydrophobic hormones like the steroids, thyroxin, vitamin D3, and all-trans retinoic acid. One intriguing aspect of nuclear hormone receptor biology is that in addition to the known receptors there are dozens of others for which a hormone (that is, a ligand) is unknown. We call these `orphan' receptors.

"In 1990 we published a paper describing one of these orphans as a receptor for a novel vitamin A derivative, which we called retinoid X (D.J. Mangelsdorf, et al., Nature, 345:224-9, 1990). Subsequently, we demonstrated that the ligand for this retinoid X receptor (RXR) was 9-cis ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies